Dilip G Shah

Last updated

Dilip Girdharlal Shah, commonly known as DG Shah, was a pharmaceutical executive who founded the Indian Pharmaceutical Alliance. Shah was a member of the first batch of the Indian Institute of Management, Ahmedabad (IIMA), which graduated in 1966. [1] At IIMA, Shah met Smita Dalal, whom he eventually married. They are considered to be the first couple in the history of IIMA. [1] Upon graduation, Shah started worked for Pfizer in 1967. He worked for Pfizer for 30 years as a Commercial Director [2] and eventually became a member of the board of directors for Pfizer-India. Shah's son Anish serves as the MD & CEO for the Mahindra Group [3] .

In 1999, Shah founded the Indian Pharmaceutical Alliance (IPA) to promote the cause of generic drugs in India and to oppose the drug intellectual property rights defined by the TRIPS Agreement. Divya Rajgopal, writing for The Economic Times, notes that: [4]

Shah and the IPA became the body that resisted the Intellectual Property Rights that lower income countries like India were forced to sign under the World Trade Organisation's TRIPS agreement. The IPA positioned itself as the voice of generic drug companies that claimed to represent the interests of Indian drug companies who were bullied under these TRIPS agreement. Shah, few pharma industry veterans recall was at times even more powerful than the Indian CEO's whose interests he represented to the bureaucrats and ministers in Delhi.

With the IPA, Shah helped Indian companies communicate with the US Food and Drug Administration (USFDA) and contributed "in the shaping of the current Indian patent law, which favours affordable medicines, while also recognising the obligations under the TRIPS agreement". [5] Shah was a member of the official Indian delegation for the World Trade Organization (WTO) ministerial conference at Cancun and testified on behalf of India in an appearance before the United States International Trade Commission (USITC). [6] He also was the author of the first book on drug pricing in India. [2]

Apart from his work with the IPA, Shah set up a company called Vision Consulting Group to consult about matters of public policy, strategy, and planning [2] and served in a variety of advisory roles. He was the Chair of the International Generic Pharmaceutical Alliance (IGPA) for two terms in 2005-07 and 2010-11, [6] a Non-Executive Independent Director of Fresenius Kabi Oncology Limited (formerly Dabur Pharma Limited), an Independent Non-Executive Director at Anuh Pharma Ltd. (October 2007-February 2019), a member of the advisory panel for PharmaGenerics UK, an Additional Director of Lyka Labs Ltd. (from July 2008 to April 2009), an editor for the Journal of Generics Medicines, and a guest faculty for the Management Development Programmes at his alma mater IIMA. [2]

Shah died on February 22, 2019. [7] The "DG Shah Award for best Public Policy Paper" at IIMA was posthumously established in his name. [8]

Related Research Articles

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

<span class="mw-page-title-main">Indian Institute of Management Ahmedabad</span> Business school in India

Indian Institute of Management Ahmedabad, is an Indian business school, located in Ahmedabad, Gujarat, India. As one of India's premier Indian Institutes of Management, the school has been accorded the status of an Institute of National Importance by the Ministry of Human Resources, Government of India in 2017. It is widely regarded as the leading business school in India and one of the most prestigious business schools in the world.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Strides Pharma Science</span> Pharmaceutical company headquartered in India

Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.

<span class="mw-page-title-main">Wockhardt</span> Pharmaceutical and biotechnology company headquartered in Mumbai, India

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company is a major producer of HIV antivirals, as well as gynaecology and blood therapeutic drugs.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

<span class="mw-page-title-main">Ashish Nanda</span>

Ashish Nanda is a business economist and professor who is the former Director of the Indian Institute of Management Ahmedabad (IIMA).

<span class="mw-page-title-main">Cadila Pharmaceuticals</span> Indian pharmaceutical company

Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

<span class="mw-page-title-main">Proprietary drug</span>

Proprietary drug are chemicals used for medicinal purposes which are formulated or manufactured under a name protected from competition through trademark or patent. The invented drug is usually still considered proprietary even if the patent expired. When a patent expires, generic drugs may be developed and released legally. Some international and national governmental organizations have set up laws to enforce intellectual property to protect proprietary drugs, but some also highlight the importance of public health disregarding legal regulations. Proprietary drugs affect the world in various aspects including medicine, public health and economy.

The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities. Ahmedabad and Vadodara are considered as pharmaceutical hubs as there are many big and small pharma companies established in these cities.

The Indian Pharmaceutical Alliance (IPA) is an association of domestic Indian pharmaceutical companies. IPA was founded in August 1999 by Dilip G Shah and six Indian drugmakers: Cipla, Dr. Reddy's, Lupin, Piramal, Ranbaxy, and Wockhardt. IPA was founded to promote the cause of generic drugs in India and has since expanded to include 24 domestic pharmaceutical companies. Sudarshan Jain is the current secretary general of the IPA.

References

  1. 1 2 Admin, D2C. "Meet the 'Shahs' - The First Family to graduate from IIM Ahmedabad // Unstop (formerly Dare2Compete)". unstop.com. Retrieved 2023-08-05.{{cite web}}: CS1 maint: numeric names: authors list (link)
  2. 1 2 3 4 "IPA Founder DG Shah passes away". www.biospectrumindia.com. Retrieved 2023-08-05.
  3. ↑ Kamath, Thomas K. Thomas & Vinay (2021-12-05). "The Shah of Mahindra". BusinessLine. Retrieved 2024-06-26.
  4. ↑ Rajagopal, Divya (2019-02-22). "D G Shah founder of Indian Pharmaceutical Alliance dies at age 77". The Economic Times. ISSN   0013-0389 . Retrieved 2023-08-05.
  5. ↑ "Indian generic industry loses a titan in DG Shah". Business Today. 2019-02-22. Retrieved 2023-08-05.
  6. 1 2 "Pharma veteran DG Shah passed away". Business Today. 2019-02-22. Retrieved 2023-08-05.
  7. ↑ "DG Shah: Indian pharma loses a significant voice on international trade and policy". www.thehindubusinessline.com. 2019-02-22. Retrieved 2023-08-05.
  8. ↑ "IP Alliance institutes 'DG Shah Award for best Public Policy Paper' at IIM Ahmedabad". pharmabiz.com. Retrieved 2023-08-05.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.